I highly suggest you use investor village as your resource versus this board. Its just all emotions fueled by fear and greed and know it all's. Truly very little substance. Blessings everyone.
Is it concerning what happened at 36 months as it dropped below baseline ? thanks
PS: If you ever make it down to CABO SAN LUCAS. I would love for you to join me for a free surf lesson, tacos and church. I don't know you brother. But, I admire your character !
Rose: that monikor must bug you. Sorry. I'm thinking ACAD could see low 30's post -positive ADCOM then start a nice move up to 40 into FDA event. Tutes should be covering hedge post adcom or at least be taking some off which should help move up. whats are the tea leaves telling you?
Expect some wild swings going into upcoming binary events. The tree will be swinging ! Bio investing is not for children. Expecting victory in Adcom and FDA ruling in May. We're witnessing the beginning of a major franchise in the making. ADP will be positive. Buyout in 2 yrs for 12bb.
whats your thought on ACAD MC post approval. I'm thinking it might stay sub 3bb as a wait and see how REV plays out. take a look at RLYP. off course ADP trial is worth value. Yet, the market has changed as multiples.
Company is taken out after ADCOM. Reps will get a thank you card for coming out with company holding no liability in form of salary or options. Regarding last raise, The BO will come from one of the large usual suspects ( CELG OR GILD ). It will be a all stock deal for about 6bb. What will make the deal palatable for the acquirer in this market is the large cash holding that comes with ACAD. The internal rollout was always plan B that needed to be funded but was also used as leverage in securing a deal. Off label use and sales will huge ! that's my humble 3 cents and my wish...